Upcoming webinar: The genetics of congenital myopathies in French Canadians
The Neuromuscular Disease Network for Canada (NMD4C) and Muscular Dystrophy Canada (MDC) are pleased to invite you to a basic science webinar on July 7 at 5:00-6:30pm EST about the genetics of congenital myopathies in French Canadians. This webinar is primarily targeted at Canadian clinicians, academics and trainees with an interest in neuromuscular disease. NMD4C and MDC are providing organisational and technical support, and this is an independent clinical/academic webinar with no industry sponsorship.
If you have any questions, please email
Register HERE
Topics and speakers:
Welcome and Introduction on Congenital Myopathies in Québec
Dr. Bernard Brais (NMD4C Investigator)
Next-Generation Sequencing Approaches for the Diagnosis of Muscle Diseases
Dr. Martine Tétreault
A Novel Recessive TNNT1 Congenital Core-Rod Myopathy in French Canadians
Dr. David Pellerin
Read next...
Sixth Annual NMD4C and MDC Clinical Fellowship Competition from Opens May 1st
Together, NMD4C and MDC are excited to open our 2027 annual funding competition to provide clinical fellowship award(s) in neuromuscular medicine and electromyography (EMG)! This annual funding competition provides one-year salary support ($80,000) for early-career clinicians to participate in Canadian neuromuscular medicine and EMG fellowship training programs.
Advancing Neuromuscular Research: MDC Awards $700k to Seven NMD4C Investigator-Led Projects
We’re proud to share that neuromuscular research led by our NMD4C Investigators and Leads; Dr. Hanns Lochmüller, Dr. Rashmi Kothary, Dr. Rami Massie, Dr. Elise Duchesne, Dr. Omid Kiamanesh, and Dr. Nicolas Dumont, have been recognized in Muscular Dystrophy Canada’s 2026 Neuromuscular Clinical and Translational Research Grant announcement. Drawing from MDC’s national funding update, we’re…
Announcing the 2026 NMD4C Award Recipients
We are excited to announce the recipients of the 2026 NMD4C Awards, recognizing excellence, leadership, and impact across Canada’s neuromuscular research community. In this fourth cycle, the program introduces two new award categories, and expand on our ability to celebrate the work of contributions of trainees and patient partners who strengthen our national network.